Home

anders Telemacos Banyan kappa opioid receptor activates p38 Roh Motto Prähistorisch

Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies | Scientific Reports
Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies | Scientific Reports

Figure 5. | Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria | Journal of Neuroscience
Figure 5. | Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria | Journal of Neuroscience

Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes - ScienceDirect
Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes - ScienceDirect

Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews
Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews

Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes - ScienceDirect
Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes - ScienceDirect

PDF] Myocardial Opioid Receptors in Conditioning and Cytoprotection | Semantic Scholar
PDF] Myocardial Opioid Receptors in Conditioning and Cytoprotection | Semantic Scholar

Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain

Molecular mechanisms of opioid receptor-dependent signaling and behavior. - Abstract - Europe PMC
Molecular mechanisms of opioid receptor-dependent signaling and behavior. - Abstract - Europe PMC

Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor - ScienceDirect
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor - ScienceDirect

Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling

κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition | Neuropsychopharmacology
κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition | Neuropsychopharmacology

Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text

Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons | Journal of Neuroscience
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons | Journal of Neuroscience

Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo

Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology | SpringerLink
Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology | SpringerLink

Dopaminergic Cellular and Circuit Contributions to Kappa Opioid Receptor Mediated Aversion
Dopaminergic Cellular and Circuit Contributions to Kappa Opioid Receptor Mediated Aversion

Frontiers | Advances in Achieving Opioid Analgesia Without Side Effects
Frontiers | Advances in Achieving Opioid Analgesia Without Side Effects

Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink

IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors?
IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors?

Kinase cascades and ligand-directed signaling at the kappa opioid receptor. - Abstract - Europe PMC
Kinase cascades and ligand-directed signaling at the kappa opioid receptor. - Abstract - Europe PMC

IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors?
IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors?

Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience

Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience

Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry

Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar

Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists